Testing effectiveness (Phase 2)Ended earlyNCT02008994
What this trial is testing
Phase II Study Using Genomic & Proteomic Profiling to Influence Treatments for Patients With Metastatic Breast Cancer
Who this might be right for
Metastatic Breast Cancer
Sanford Health 5